戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ine of platinum-based chemotherapy (platinum-refractory).
2 ), and 128 (87%) of 148 patients were double refractory.
3  or an immunomodulatory drug, or were double refractory.
4 ypes, including glioblastoma, remain largely refractory.
5 ion of newer treatment options for resteroid-refractory acute and chronic GVHD.
6 magnesium with albuterol among children with refractory acute asthma.
7                 Patients who develop steroid-refractory acute graft-versus-host disease (aGVHD) after
8 but the development of severe and/or steroid-refractory acute graft-versus-host disease (aGVHD) remai
9                 Steroid-resistant or steroid-refractory acute graft-versus-host disease (SR-aGVHD) po
10 ic stem cell transplantation without steroid-refractory acute graft-versus-host disease and without e
11       Here, we propose to define ruxolitinib-refractory acute GVHD as disease that shows: (1) progres
12 approved for the treatment of corticosteroid-refractory acute GVHD in adult and pediatric patients 12
13      No differences were detected in steroid-refractory acute GVHD, disease-free survival, relapse, n
14       Outcomes for children with relapsed or refractory acute myeloid leukaemia remain poor.
15 aediatric patients with heavily relapsed and refractory acute myeloid leukaemia suggests that this co
16 rapy in paediatric patients with relapsed or refractory acute myeloid leukaemia.
17 s in patients with IDH2-mutated, relapsed or refractory acute myeloid leukaemia.
18                     Treatment of relapsed or refractory acute myeloid leukemia (AML) has presented ch
19 ses with promising activity in patients with refractory advanced GIST.
20 overall survival, for patients with platinum-refractory advanced urothelial carcinoma.
21 mprove progression-free survival in platinum-refractory, advanced urothelial carcinoma.
22 atients had disease that had relapsed or was refractory after the receipt of up to five previous ther
23 he effect of three neuroleptic strategies on refractory agitation in patients with cancer with termin
24 erson Cancer Center (Houston, TX, USA), with refractory agitation, despite low-dose haloperidol, were
25  least 12 years with grades II to IV steroid-refractory aGVHD were eligible to receive ruxolitinib or
26 ith historical data in patients with steroid-refractory aGVHD who otherwise have dismal outcomes.
27 re used to manage complications of medically refractory AKI and CRS and may restore normal electrolyt
28  28 patients; 42-76), and 62% in relapsed or refractory AML (34 of 55 patients; 49-74).
29 d molecularly defined subsets of relapsed or refractory AML.
30 c myelomonocytic leukaemia); and relapsed or refractory AML.
31 nths (95% CI 6.6-not reached) in relapsed or refractory AML.
32 unity to revisit the approach to relapsed or refractory AML.
33  secondary AML, and 55 (33%) had relapsed or refractory AML.
34       We describe our experience of cases of refractory anaphylaxis at in-hospital challenge and prop
35 ioblastoma remains one of the most treatment refractory and fatal cancers.
36                                              Refractory and recurrent disease is common, leading to l
37 ck an initial response to therapy (i.e., are refractory), and although the mean survival of MM patien
38              Our results suggest that highly refractory arc mantle relicts are entrained in the upper
39                   ECMO has a role in severe, refractory ARDS associated with COVID-19.
40 port (exposed) were matched with patients in refractory arrest (at risk of intra-arrest transport) at
41 ective beta-blockers (NSBB) in patients with refractory ascites or spontaneous bacterial peritonitis
42   The results demonstrate that children with refractory asthma and neutrophilic inflammation had a BA
43       Although mechanisms for corticosteroid refractory asthma are likely to be numerous, the develop
44 r treating some patients with corticosteroid refractory asthma.
45               Patients with symptomatic drug-refractory atrial fibrillation (paroxysmal and persisten
46 d for spontaneous spleen rupture, or to cure refractory autoimmune haemolytic anemia.
47 nti-CD19 (LV20.19) CAR T cells for relapsed, refractory B cell malignancies.
48                                              Refractory B cell responses to T cell-independent (TI) c
49  and histone deacetylase inhibitor abrogated refractory B-1b cell immune responses against Gal-glycan
50    TLR inhibitor together with CNI abrogated refractory B-1b cell immune responses against the ABO-bl
51 ated in children and adults with relapsed or refractory B-cell acute lymphoblastic leukaemia.
52 therapy has proven effective in relapsed and refractory B-cell malignancies, but resistance and relap
53 -agent activity in patients with relapsed or refractory B-cell malignancies.
54 notherapeutic strategy for treating multiple refractory blood cancers, but further advances are requi
55 e of both TNBC and HER2-positive trastuzumab-refractory breast cancer.
56 ds to be improved to fit in the managemet of refractory calculi.
57 rohydraulics in fragmentation and removal of refractory calculi.
58 ide a paradigm for imaging latent, treatment-refractory cancer cells, suggesting that DNP-MRSI provid
59                                 A variety of refractory cancers (2.0% of those screened) had MMR defi
60  liberation of "old" (6855 +/- 120 years BP) refractory carbon as dissolved organic carbon (DOC).
61 own survival benefit in select patients with refractory cardiac arrest but there is insufficient data
62 013 and 2016, we identified patients who had refractory cardiac arrest in the ED.
63                    Consecutive patients with refractory cardiogenic shock (cardiac arrest excluded) w
64 namics and microcirculation in patients with refractory cardiogenic shock and compared the evolutions
65 roves between childhood and adolescence, but refractory cases have been noted.
66 s, but additional therapies are required for refractory cases.
67 m cord blood to 11 patients with relapsed or refractory CD19-positive cancers (non-Hodgkin's lymphoma
68 n indication for SBCE) to newer ones such as refractory celiac disease, hereditary polyposis syndrome
69                                              Refractory cellular immune responses, immunosuppression-
70  stimulation (DBS) is a treatment option for refractory chronic cluster headache (CCH).
71  rituximab (BR) in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
72 romodulation treatment for the management of refractory chronic pain syndromes.
73 rs of age diagnosed with H(1) -antihistamine-refractory chronic spontaneous urticaria (without induci
74 g of the cohort of patients with relapsed or refractory classical Hodgkin lymphoma was a post-hoc dec
75 phase 1b/2 study, 134 patients with relapsed/refractory CLL or SLL (median age, 66 years [range, 42-8
76  and June 2016, 42 patients with relapsed or refractory CLL were enrolled in this study and 38 were i
77 rapy in first-line and treatment of relapsed/refractory CLL.
78  demonstrate mixed efficacy in patients with refractory CMV infection suggesting that letermovir may
79 el therapeutic options for drug-resistant or refractory CMV infection, including maribavir, letermovi
80 when applied to treatment-naive and relapsed/refractory cohorts individually.
81 single infusion cohort, 3 of 6 patients with refractory CRS concurrent with culture-positive sepsis d
82                   Morbidity and mortality of refractory CS remain high.
83 n = 2; chronic lymphoid leukemia, n = 1; and refractory cytopenia with multilineage dysplasia, n = 1)
84                     The removal mechanism of refractory deep-ocean dissolved organic carbon (deep-DOC
85 onotherapy for patients with relapsed and/or refractory diffuse large B cell lymphoma.
86 n encouraging activity against recurrent and refractory diffuse large B cell lymphomas (DLBCL).
87 high proportion of patients with relapsed or refractory diffuse large B-cell lymphoma ineligible for
88                    Patients with relapsed or refractory diffuse large B-cell lymphoma who are ineligi
89 NA-seq on skin and blood from a patient with refractory DiHS/DRESS, identifying the JAK-STAT signalin
90 e large B-cell lymphoma, who relapsed or had refractory disease after previous treatment with one to
91                      A small proportion have refractory disease and may benefit from an alternate tre
92 patient underwent to colectomy for a medical refractory disease and the histological examination of t
93                                 Recurrent or refractory disease can be effectively treated or cured w
94 chemotherapy group (hazard ratio for primary refractory disease or first occurrence of progression, r
95 5 years or older, 181 (67%) had chemotherapy-refractory disease, and seven (3%) had secondary CNS inv
96 ies, virtually all develop progressive, drug-refractory disease.
97 ons for patients with macrolide-resistant or refractory disease.
98 on may reflect CMB accrual over time or more refractory disease.
99 acute myeloid leukemia (AML) is chemotherapy refractory disease.
100 fficacy in murine HLH models and humans with refractory disease.
101 ble at first relapse or first designation of refractory disease.
102                             Overall, 10% had refractory disease.
103 leukin-33 (IL-33) plays an important role in refractory disorders such as asthma, allergic rhinitis a
104 ifier to pretreatment biopsies from relapsed/refractory DLBCL patients receiving avadomide (NCT014215
105 , demonstrated clinical activity in relapsed/refractory DLBCL patients, independent of COO subtypes.
106 nuclear export, in patients with relapsed or refractory DLBCL who had no therapeutic options of poten
107  events profile in patients with relapsed or refractory DLBCL who received at least two lines of prev
108  We describe two patients who presented with refractory dysphagia due to malignant proximal oesophage
109 n patients with COPD who experience advanced refractory dyspnea despite otherwise optimal therapy.Con
110 otential therapy for patients with rituximab-refractory EBV-associated lymphoma after transplantation
111 ering event, rare patients develop treatment-refractory electrical storm and their hemodynamic instab
112 orporeal membrane oxygenation-supported drug-refractory electrical storm patients, 42% survived 6 mon
113  from the sensorimotor cortex of people with refractory epilepsy and classified five facial expressio
114 dividuals had neurodegenerative disease with refractory epilepsy, developmental regression, and reduc
115 surgical planning in patients with medically refractory epilepsy; however, their spatial and temporal
116  eye movement (REM) sleep, in six medication-refractory focal epilepsy patients during epilepsy monit
117                        In every patient with refractory focal epilepsy presumed to be lesional, evalu
118 patients with previously treated relapsed or refractory follicular lymphoma (grade 1, 2, or 3a) were
119 heavily pretreated patients with relapsed or refractory follicular lymphoma.
120 )) that have higher vapor pressures than the refractory form (i.e., UO(2)) depending on the oxygen ab
121 could be used to enhance immune clearance of refractory fungal, mycobacterial, and viral infections.
122                                              Refractory gastroesophageal reflux disease (GERD) reduce
123       In a randomized trial of patients with refractory GERD, adding 1500 mg IW-3718 to label-dose PP
124                                              Refractory glaucoma was defined as IOP >21 mmHg on maxim
125 ed with a patch graft in pediatric and adult refractory glaucomas.
126     A single-phase body-centered-cubic (BCC) refractory HEA, NbTaTiVZr, using thermodynamic modeling
127  In total, 61 other patients (52%) developed refractory heart failure to disabling New York Heart Ass
128  centers involving patients with relapsed or refractory HL and administered CD30.CAR-Ts after lymphod
129                                  In relapsed/refractory Hodgkin lymphoma (R/R HL), immunotherapies su
130 vity in paediatric patients with relapsed or refractory Hodgkin lymphoma, consistent with experience
131 xhibit activity in patients with relapsed or refractory Hodgkin lymphoma.
132        This case documents a rare finding of refractory hypercalcaemia of underlying malignancy due t
133 zygous familial hypercholesterolemia who had refractory hypercholesterolemia, with a screening LDL ch
134 setts, 6 patients were placed on VV ECMO for refractory hypoxemic respiratory failure.
135  randomized trial of patients with treatment-refractory IBS with predominant bloating, FMT relieved s
136       Nevertheless, studies of a murine iron-refractory iron-deficiency anemia-causing mutant (Mt2I28
137 y off-label use of Tpo-RAs for severe and/or refractory ITP during pregnancy seems safe for both moth
138 ological events in patients with relapsed or refractory large B-cell lymphomas, including those with
139  patients (aged >=18 years) with relapsed or refractory large B-cell lymphomas.
140 rospectively from all patients with relapsed/refractory LBCL who underwent leukapheresis as of Septem
141 ical responses in patients with relapsed and refractory LCH treated with BRAF or MEK inhibitors, alth
142 or biopsy specimens from 5,954 patients with refractory malignancies at 1,117 accrual sites were anal
143 f CAR T cells for patients with relapsed and refractory mantle cell lymphoma following prior failed B
144 s in a majority of patients with relapsed or refractory mantle-cell lymphoma.
145 hat the main constituent is a mix of ice and refractory materials characterized by high porosity (70-
146 table and pre-existing NGFR(hi) multitherapy-refractory melanoma subpopulation, which ought to be eli
147 ed a total of 111 patients who had treatment-refractory meningioma and received SSTR-targeted PRRT.
148 ciated with SSTR-targeted PRRT for treatment-refractory meningioma.
149 epresents a promising approach for treatment-refractory meningiomas.
150 f)(x) are high strength and damage resistant refractory metals that also exhibit superconductivity wi
151  immunotherapy in 10 patients with anti-PD-1-refractory metastatic melanoma.
152 n patients with heavily pretreated, platinum-refractory metastatic urothelial carcinoma with measurab
153  clinical trial in patients with relapsed or refractory MM (NCT03399799).
154 years or older with relapsed or relapsed and refractory multiple myeloma (as per International Myelom
155 melflufen plus dexamethasone in relapsed and refractory multiple myeloma (RRMM), a population with an
156 =18 years) if they had confirmed relapsed or refractory multiple myeloma according to International M
157 vival versus Kd in patients with relapsed or refractory multiple myeloma and was associated with a fa
158 fficacy with tolerable safety in relapsed or refractory multiple myeloma in a phase 1 study.
159 Europe, Australia, and Asia with relapsed or refractory multiple myeloma were randomly assigned 2:1 t
160 G 420 was assessed in patients with relapsed/refractory multiple myeloma.
161 eavily pre-treated patients with relapsed or refractory multiple myeloma.
162 vel treatments for patients with relapsed or refractory multiple myeloma.
163  safety profile in patients with relapsed or refractory multiple myeloma.
164 d dexamethasone in patients with relapsed or refractory multiple myeloma.
165  safety profile in patients with relapsed or refractory multiple myeloma.
166  findings provide further explanation of the refractory nature of respiratory illnesses in smokers an
167 antitumor activity in patients with relapsed/refractory neuroblastoma.
168 e often associated with more severe, steroid-refractory neutrophilic asthma.
169  children and young adults with recurrent or refractory non-CNS solid tumours or lymphoma.
170 antibodies in heavily pretreated relapsed or refractory non-Hodgkin lymphoma warrants further investi
171 ogically confirmed CD20-positive relapsed or refractory non-Hodgkin lymphoma, had an Eastern Cooperat
172 us obinutuzumab in patients with relapsed or refractory non-Hodgkin lymphoma.
173 r deep brain stimulation (DBS) for treatment-refractory obsessive-compulsive disorder (OCD) can be co
174 effective treatment option for patients with refractory obsessive-compulsive disorder (OCD).
175 ess of DBS in an open study of patients with refractory OCD.
176 nificant improvement in severe cases (HDIVig refractory or cases with central nervous system or cardi
177 once daily (QD) in 48 patients with relapsed/refractory or high-risk treatment-naive CLL.
178 s shown remarkable activity in patients with refractory or relapsed acute lymphocytic leukaemia.
179 s of apoptosis, especially in the context of refractory or relapsed BRAF(V600E)-driven melanoma.
180                                Children with refractory or relapsed Burkitt lymphoma (BL) or Burkitt
181  All received letermovir in the context of a refractory or resistant CMV infection including asymptom
182 ens new treatment opportunities for chronic, refractory pain, and pruritis.
183                                         Drug refractory, paroxysmal AF was the most common ablation i
184 aive patients and 23 (25%) of 92 relapsed or refractory patients discontinued treatment on study.
185 atment-naive patients and 50% of relapsed or refractory patients had undetectable minimal residual di
186 ponse and 86 (93% [86-98]) of 92 relapsed or refractory patients per both the modified 3rd and 6th IW
187        Procedures were also performed in PPI-refractory patients with FD ("FD-stoppers") before and 8
188 loma cells from newly diagnosed and relapsed/refractory patients, including plasma cells bearing the
189 aive patients and 21.5 months in relapsed or refractory patients, the median progression-free and ove
190 emission (CR) and durable response in highly refractory patients.
191 ssion is the first-line surgery in medically refractory patients.
192 on in the clinical management of gemcitabine-refractory PDAC.
193 tis with a reduced support, and 3) recurrent/refractory peri-implantitis.
194 ing results in a phase II study in recurrent/refractory pericarditis.
195 d-line treatment for patients with recurrent/refractory pericarditis.
196                      This previously unknown refractory period of ADCP, or hypophagia, was observed i
197 vention was prolongation of atrial effective refractory periods, at least in part attributable to the
198 indication (class I, 53.6%) followed by drug refractory, persistent AF (class I, 41.8%).
199 rial extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock.
200 ural proteome, promising such information on refractory protein targets.
201  challenges of using CAR-T therapy to manage refractory PTLD in SOT recipients and its possible compl
202 e drastically improved outcomes for relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (AL
203 ly reported durable responses in relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) pati
204               Treatment options for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) a
205 tion, which we designate as non-inflammatory refractory RA (NIRRA).
206 hich we designate as persistent inflammatory refractory RA (PIRRA); and those with supposed refractor
207  Future approaches towards the definition of refractory RA and the application of single-cell and int
208  omics technologies to the identification of refractory RA endotypes are also discussed.
209                               This Review of refractory RA focuses on two types of patients: those fo
210 fractory RA (PIRRA); and those with supposed refractory RA who have continued disease activity that i
211 tential therapeutic approach in the anti-TNF refractory RA.
212 fficult to treat', 'treatment-resistant' or 'refractory' RA.
213 type 17 (Th17) cells is a leading feature of refractory rejection.
214 tients with aggressive metastatic disease or refractory/relapsed neuroblastoma currently face a disma
215 landscape at the Pou5f1/Oct4 promoter, and a refractory response to differentiation cues.
216 a history of developmental delay and medical refractory seizures since birth most recently presented
217        Partial and unsustained conversion of refractory sodium nitrate (NaNO(3)) was observed at the
218 rally confirmed, PD-L1-positive, relapsed or refractory solid tumour or lymphoma, and a Lansky Play/K
219 ngle-centre cohort of patients admitted with refractory status epilepticus from 2016 to 2019.
220 anaesthetic agents are typically titrated in refractory status epilepticus to achieve either seizure
221 -choice, second-line drug for benzodiazepine-refractory status epilepticus.
222 ession of ZEBRA, resulting in responsive and refractory subpopulations.
223 istent increase in vagal tone that may cause refractory symptoms even in a normal heart patient.
224 No established treatments exist for relapsed/refractory systemic light-chain (AL) amyloidosis.
225 netic and cellular) that cause anticoagulant-refractory thrombotic antiphospholipid syndrome are now
226                                Anticoagulant-refractory thrombotic antiphospholipid syndrome can be b
227 ing radioiodine effectiveness in radioiodine-refractory thyroid cancer.
228 rmation Processing Battery in 145 unilateral refractory TLE patients undergoing epilepsy surgery, a v
229 y surgery, a validation set of 55 unilateral refractory TLE patients, and 39 age- and sex-matched hea
230 , offers new hope as a therapeutic agent for refractory TLE.
231 ide incentives for offering early surgery in refractory TLE.
232 ad multiple myeloma and had relapsed or were refractory to 2 or more previous lines of treatment that
233 aintaining a strengthened arterial framework refractory to AAA.
234 tcomes of clinical trials of cancer patients refractory to all other treatments provide support for t
235                       Two of 5 patients were refractory to all treatments and demonstrated phthisis b
236 ts with cardiogenic shock and concomitant VT refractory to antiarrhythmic drugs on mechanical support
237 characterized by severe, symptomatic ascites refractory to attempts at medical and surgical managemen
238 lator, in patients with rheumatoid arthritis refractory to biologic disease-modifying antirheumatic d
239        In patients with rheumatoid arthritis refractory to biologic DMARDs, upadacitinib was superior
240 or and immunomodulatory drug, or were double refractory to both a proteasome inhibitor and immunomodu
241                        Cystoid macular edema refractory to carbonic anhydrase inhibitor therapy and u
242 gle-cell analysis identifies arterial ECs as refractory to CCM transformation.
243 DS) that is rapidly progressive, severe, and refractory to conventional therapies.
244 ged 18 years or older, had cancers that were refractory to conventional treatment or for which no con
245 support for sepsis-induced cardiogenic shock refractory to conventional treatments.
246 f pharmacologic interventions for inpatients refractory to corticosteroids, in reducing risk of colec
247 d because most laboratory rodent species are refractory to disease.
248 ive breast cancer or in patients with tumors refractory to endocrine therapy.
249 h the majority of females become permanently refractory to further mating.
250 eukaemia (defined as blasts >=20% but <=30%) refractory to hypomethylating agents and with an Eastern
251 nts with high-risk myelodysplastic syndromes refractory to hypomethylating agents is less than 6 mont
252 omes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents.
253             Ovarian cancer has thus far been refractory to immunotherapies that stimulate the host im
254 ma IFNalpha2 levels, implying that pDCs were refractory to in vitro stimulation after IFNalpha produc
255 y, neonatal mice (Day 14 and 21) were highly refractory to induction of cell shedding after intraperi
256 found that a strain of Aedes aegypti that is refractory to infection by Dirofilaria immitis, the agen
257 mase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced.
258 arteriovenous malformations in zebrafish are refractory to inhibition of the downstream effector PI3K
259 o mometasone furoate in patients with CRSwNP refractory to intranasal corticosteroids (INCS) signific
260 t of microglia with ZL0580 renders them more refractory to latent HIV reactivation, indicating an epi
261 tion of patients, for example, those who are refractory to medical treatment or those who develop col
262  as mutation of Cys-1039 rendered the kinase refractory to MFH290 and restored Pol II CTD phosphoryla
263 hrombotic disease observed, which has become refractory to oral anticoagulation.
264 th rituximab showing efficacy in retinopathy refractory to other agents.
265 2, which render pDCs and late DC progenitors refractory to physiological stimuli controlling pDC func
266 oT(R155Q,R271Q,R284Q) (ProT(QQQ)), a variant refractory to prothrombinase- or thrombin-mediated cleav
267           We found that transformed NSCs are refractory to quiescence-inducing signals.
268 t population that would now be considered as refractory to ruxolitinib vs ruxolitinib dependent.
269  by both STAT3 and ER, IL6/STAT3 activity is refractory to standard ER-targeted therapies.
270 rthermore, LSCs from both AML and CML can be refractory to standard-of-care therapies and persist in
271                            Many proteins are refractory to targeting because they lack small-molecule
272                              Nucleosomes are refractory to TF binding, and often must be removed from
273  In contrast, we show that infected HPCs are refractory to TGF-beta signaling as another HCMV miRNA,
274                              HeLa cells were refractory to the growth of human H1N1 and H3N2 viruses
275           It is unclear why some tissues are refractory to the mitogenic effects of the oncogene Myc.
276 ge, one to nine therapies), of whom 40% were refractory to their previous therapy, received ibrutinib
277 d non-human primates while mice and rats are refractory to these effects.
278                  Many patients, however, are refractory to this treatment or relapse after an initial
279 t patients with COVID-19 respiratory failure refractory to traditional critical care management and o
280         Eligible patients were unsuitable or refractory to trans-arterial chemoembolization (TACE) an
281 ognitive functions, including those that are refractory to treatment with current medications.
282 ctivity." CONCLUSIONS: In adults with CRSwNP refractory to treatment with INCS alone, the addition of
283 t might be important in H. pylori infections refractory to treatment.
284 us score of 2 or lower, and were relapsed or refractory to, or ineligible for, standard treatments.
285 herapy for select cases of severe, treatment-refractory Tourette syndrome; however, patient responses
286 ajority of intracellular protein targets are refractory toward small-molecule therapeutic engagement,
287 cular axis and a potential target for immune-refractory tumor.
288 T) cell therapies can eliminate relapsed and refractory tumors, but the durability of antitumor activ
289 antinib in patients with metastatic platinum-refractory urothelial carcinoma.
290 ients with cardiogenic shock and concomitant refractory ventricular arrhythmia undergoing bailout abl
291 ted resuscitation for patients with OHCA and refractory ventricular fibrillation significantly improv
292 ar fibrillation, more than half present with refractory ventricular fibrillation unresponsive to init
293 ard ACLS treatment in patients with OHCA and refractory ventricular fibrillation.
294 er out-of-hospital cardiac arrest from shock-refractory ventricular fibrillation/pulseless ventricula
295 ated survival in 160 consecutive adults with refractory ventricular fibrillation/ventricular tachycar
296  gastroparesis) with chronic (>12 months) of refractory vomiting (idiopathic, associated with a type
297 lectrical stimulation (GES) for treatment of refractory vomiting, associated or not with gastroparesi
298 patients with treatment-naive, or relapse or refractory Waldenstrom macroglobulinemia.
299                Among cases that were primary refractory, we identified heterogeneous and sometimes di
300 re typically highly aggressive and treatment-refractory, yet RAS mutation itself is insufficient for

 
Page Top